Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
AVI BioPharma Strengthens Patent Position in Exon Skipping
AVI BioPharma, 11/25/08
AVI BioPharma, Inc., a developer of RNA–based drugs, announced the signing of an exclusive worldwide license agreement with the University of Western Australia (UWA) to a patent application related to the treatment of Duchenne Muscular Dystrophy (DMD).
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09
Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR
Mylan, 12/09/09
Article Search
Sponsor